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 Hemogenic endothelium involves the specification of a hematopoietic stem 
cell (HSC) from an existing endothelial cell.  It, along with common developmental 
origins, co-regulation, and shared niches are examples of the close ties the 
hematopoietic and endothelial lineages share in development.  As a significant 
portion of total HSCs are generated via a hemogenic endothelium intermediate, 
modulation of this pathway is expected to impact both hematopoietic and endothelial 
development.  Currently, our understanding of how endothelial cells transition to the 
HSC lineage is still limited.  We found that non-aortic endothelial cells, specifically 
venous endothelial cells, can undergo the transition to an HSC lineage, suggesting 
that hemogenic capacity is a more general characteristic of endothelial cells then 
previously appreciated.  Upon further analysis, we found that they were positive for 
venous specific markers and hematopoietic transcription factors.  We identified a 
potential homolog of Platelet Endothelial Cell Adhesion Molecule 1 (PECAM1) in 
zebrafish, characterized its expression during development.  It is expressed in a 
manner consistent with PECAM1 and is involved in flow-dependent process.  Finally, 
we find that loss of this PECAM1-like molecule is capable of modulating 
hematopoiesis, suggesting that the vascular and hematopoietic share common 
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CHAPTER 1 
Hematopoietic and Vascular Systems Overlap to Coordinate Function 
The endothelial and hematopoetic lineages share a close developmental 
relationship, characterized by a common progenitor, close development, shared 
signaling cues, and even the ability of endothelial cells to transdifferentiate into 
hematopoietic progenitors[1-6].  The interdependence of the hematopoietic and 
vascular systems was first demonstrated by detailed studies of the vascular mutant 
cloche which lacks all endothelial and hematopoietic cells[7].  Though these mutants 
lack all cells of both lineages, the defect in endothelial cells is cell-autonomous, 
while the defect in hematopoietic cells is non-cell autonomous[7].  This suggests that 
in cloche mutants, the hematopoietic system is suffering from the lack of an intact 
vascular system.  Understanding the interconnectedness of these two systems has 
significance, as dysfunction in either system has the ability to perturb human health.  
The cardiovascular system is responsible for the delivery of blood, nutrients, and 
oxygen to all tissues and organs of the body.  Dysfunction of the vascular 
endothelium has been tied to diabetes, atherosclerosis, and tumor angiogenesis[8-
11].  The blood carried by the cardiovascular system includes erythrocytes and 
immune cells produced by the hematopoietic system.  Specific misregulation of the 
hematopoietic system can result in leukemias and auto-immune disease as well as 
generally perturb nutrition and health[12, 13].  Given the necessity of endothelial 
cells in regulation of the hematopoietic system, it is likely that better understanding 
of the interaction between these two lineages will aid our current knowledge of the 
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role of endothelial cells in regulating hematopoietic cells, and add significantly to our 
knowledge about organism health. 
 
Vascular Development of Zebrafish 
The vascular system is characterized by a lumenized vessel lined with 
endothelial cells carrying blood to the tissues of an organism.  The endothelial cells 
lining the vessels have a stereotypic morphology, polarized and aligned in the 
direction of blood flow.  They are identified by expression of specific vascular genes, 
including Platelet Endothelial Cell Adhesion Molecule-1 (PECAM1), Vascular 
Endothelial Growth Factor Receptor-2 (VEGFR2, or kdrl in zebrafish), and Vascular 
Endothelial Cadherin (VE-Cadherin).  In zebrafish, expression of vascular markers, 
such as kdrl and ve-cadherin, is detectable as early as 12 hours post fertizlization 
(hpf)[14].  However, the predisposition of certain cells towards endothelial (and 
hematopoietic) lineages begins much earlier than that, starting during gastrulation of 
the embryo[1].  During gastrulation, endothelial cells are specified from the ventral 
mesoderm.  These cells migrate to the lateral plate mesoderm at 12hpf, where they 
coalesce to form a vascular cord.  By 18hpf, these endothelial cells have formed a 
single vessel throughout the length of most of the organism[15].  As the endothelial 
cells coalesce, an additional subset of endothelial migration occurs[15].  These two 
waves of endothelial specification and migration are followed by the lumenization of 
the vascular cord and the determination of arterial or venous identity.  Within the 
vascular cord, individual endothelial cells begin to express either Ephrin Type-B 
Receptor 4 (EphB4) in veins or Ephrin-B2 in arteries[16].  Once arterial/venous 
- 3 - 
 
identity is determined, venous endothelial cells are separated from their arterial 
neighbors and migrate to form the cardinal vein[16].  By 24hpf, the initial wave of 
vascular patterning is complete.  Embryos have a dorsal aorta spanning the length 
of the embryo, carrying blood flow away from the heart, a cardinal vein, also 
spanning the length of the embryo, carrying blood back to the heart, and intersomitic 
vessels (ISVs) have sprouted dorsally from the aorta and are beginning to 
anastomoze to form the dorsal longitudinal anastomotic vessel (DLAV) (Figure 
1.1)[15, 17, 18]. 
At 24hpf, the 2-chambered zebrafish heart has formed and begins contracting 
which pushes blood throughout the body of the embryo.  Though, at this early stage, 
the flow is primarily of plasma, it allows a flow-dependent remodeling of the venous 
vascular plexus.  In the caudal-most region of the vascular system, the cardinal vein 
sprouts ventrally to form a second venous vessel[19, 20].  This second vessel, 
termed the ventral vein, is mostly intact by 36hpf, and by 48hpf, it carries an equal 
share of the venous blood flow.  As blood flow is transferred to the ventral vein, the 
dorsal vein constricts and carries less blood.  By 72hpf, the dorsal vein is no longer a 
significant carrier of blood flow and has become predominantly a site of 
hematopoietic development (Figure 1.1). 
As remodeling of the caudal plexus is occurring, differentiation of endothelial 
cell identity is stabilizing, such that markers of venous and arterial identity are 
detectable in specific vessels.  EphB4, Disabled homolog 2 (Dab2), and Fms-related 
tyrosine kinase 4 (Flt4) are all expressed in venous endothelial cells, whereas Notch, 
T-box 20 (Tbx20), and EphrinB2 are expressed in arterial cells.  An additional third 
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class of molecules is expressed heterogeneously throughout all endothelial cells, 
such as SRY-related HMG-box transcription factor SOX17 (Sox17), and even within 
arteries, Delta like ligand 4 (Dll4) and Flt-4 levels vary depending on tip or stalk cell 
identity. Thus, endothelial cells are a diverse set of cells as they are specified at 
varied timepoints, have different identities, and different subsets of gene expression 
within those identities.  Though it seems that endothelial cells are a heterogeneous 
population, for these studies, a uniform cell identity of kdrl expression was used to 
define endothelial cells (Figure 1.1).  
 
Hematopoietic Development in Zebrafish 
The hematopoietic system is also a diverse set of cells.  Erythrocytes, 
macrophages, myeloid cells, thrombocytes, and lymphocytes (both B and T-cells) 
are all derived from the same hematopoietic stem cells (HSCs)[21, 22].  Thus the 
development and specification of HSCs is of incredible interest to the fields of 
immunity, nutrition, and health.  Multiple studies have sought to characterized the 
HSCs, and have identified multiple markers of hematopoietic potential, including c-
myb, runt-related transcription factor 1 (runx1), CD41, c-kit and VE-cadherin.  
Unfortunately, many of these markers have limitations as to their usefulness for 
scientific investigation.  For instance, CD41 is expressed on lymphocytes, and VE-
Cadherin is a marker of endothelial cells[21, 23-25].  Runx1 expression is more 
variable, due to being expressed more transiently during hematopoietic 
specification[26, 27].  Though c-myb is expressed in some neuronal tissues, it 
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remains as the most reliable single marker of hematopoietic stem cell fate for 
experiments where more than one marker cannot be utilized.   
During development, hematopoietic cells have heterogeneous in origin.  Most 
notably, hematopoiesis is initiated two different forms[28-30].  The first wave of 
hematopoiesis, termed primitive hematopoiesis, initializes in the yolk sac by 16hpf.  
It occurs primarily in the ventral mesoderm and intermediate cell mass (ICM) of 
zebrafish, similar to the ventral mesoderm and the yolk sac blood islands in mice.  
This form of hematopoiesis does not self-renew and only produces erythrocytes and 
myeloid cells[21, 30, 31].  In zebrafish, it is replaced starting at about 24hpf, by 
definitive hematopoiesis.  By 36hpf, definitive hematopoiesis is the primary form of 
hematopoiesis occurring in the embryo and will continue throughout the life of the 
organism.  Definitive hematopoiesis is distinguished from primitive hematopoiesis in 
that it: 1) produces all blood lineages including erythrocytes, lymphocytes, 
macrophages, and myeloid cells, and 2) includes HSCs capable of self-renewal, 
which allows them to be maintained throughout the life of the organism (Figure 
1.1)[21, 32].   
This wave of definitive hematopoiesis will continue past development and into 
adulthood, in specialized niches.  During development, these niches are transient 
and colonized successively.  In zebrafish, definitive hematopoiesis is initiated in the 
Aorta-gonad-mesonephros (AGM), however, it progresses to the caudal 
hematopoietic tissue (CHT), and finally to the kidney (Figure 1.1)[30].  This is very 
similar to the situation in mammals, where the onset of definitive hematopoiesis is 
also in the Aorta-Gonad-Mesonephros (AGM) region, and later it can be detected in 
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the fetal liver, and then finally in the bone marrow[21].   Post-development, 
hematopoietic stem cells settle into a final specialized vascular niche, and 
hematopoiesis continues.  For mammals, this adult niche is the bone marrow, and 
for zebrafish it is the kidney marrow[21].  This may be due to the lack of bone 
marrow in zebrafish to provide the microenvironment for HSCs.  Interestingly, it is 
not clear if these niches are capable of producing hematopoietic progenitors de novo 
from the surrounding tissue and/or endothelium, or if the HSCs arising from the AGM 
colonize each successive niche. This is especially pertinent as reports have 
documented the de novo development of definitive hematopoiesis in tissues outside 
of the AGM, such as the placenta.   
 
Association between the endothelial and hematopoietic lineages during 
development 
Though it is interesting to note the many of instances of heterogeneity 
occurring within endothelial and hematopoietic lineages, it is also noteworthy that 
while these two lineages are quite diverse within their cell type, they also have many 
ties common to both lineages.  They can arise from a common progenitor, termed a 
hemangiobast.  They are specified in close spatial and temporal proximity, and they 
have multiple common signaling pathways, including Notch, Bone Morphogenic 
Proteins (BMPs), and hemodynamic force.  Moreover, specific subtypes of 
endothelial cells can trans-differentiatiate as hematopoietic progenitors (Figure 1.2). 
The hemangioblast is a progenitor cell capable of giving rise to both 
hematopoietic and endothelial lineages.  It was originally hypothesized to exist due 
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to the close spatial and temporal development of blood and endothelial cells, as is 
seen in blood islands.  Lineage tracing studies and single cell derived colony forming 
assays have since demonstrated that such progenitors do exist[1, 33].  As 
endothelial cells are being specified during gastrulation, a small subset of those cells 
specified will give rise to both endothelial and hematopoietic cells[1, 15].  However, 
this cell type is rare, and most specified cells will produce either hematopoietic or 
endothelial cells, but not both[1].  The significance of this population is not yet clear 
(Figure 1.2A).  
One potential regulator of the hemangioblast ‘switch’ is Notch signaling, which 
has been shown to modulate the number of endothelial or hematopoietic cells at the 
expense of the other cell type[2].  Thus, Notch can drive the endothelial-
hematopoietic balance.  Notch signaling has emerged as a key regulator of multiple 
facets of hematovascular biology.  Within endothelial cells, Notch signaling promotes 
arterial fate[34].  Increased notch activity promotes tip cell identity and loss of the 
inhibitory ligand, dll4, results in increased sprouting and ectopic angiogenesis[35, 
36].  Within hematopoietic cells, Notch activity is required for cell identity.  Notch 
mutants, mindbomb, fail to specify HSCs[2, 29, 37-39].  Interestingly, these roles for 
Notch appear to be distinct in that arterial specification is not required for 
hematopoietic development (Figure 1.2B). 
Other than Notch signaling, multiple other signaling cues are shared between 
the hematopoietic and vascular systems.  BMPs, wnts, and Fibroblast Growth 
Factors (FGFs) have all been shown to elicit responses on both the hematopoietic 
and vascular fields[40-44].   In each of these cases, specificity appears to be 
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achieved by modulation of the specific ligand/receptor complex.  For example, BMP2 
signaling acts specifically on veins to promote angiogenesis of existing vessels, 
while BMP4, which is structurally similar to BMP2, has been shown to drive 




In addition to diverse signaling pathways which influence both lineages, 
environmental factors also substantially affect the development of both endothelial 
and hematopoietic lineages.  For instance, blood flow appears to modulate both 
hematopoietic and endothelial cells[47-49].  The flow of blood through a vessel, 
whether arterial or vein, has been shown to elicit responses from the endothelium.  It 
is thought that the movement of the blood over the endothelial cells exposes the 
endothelium to a shear stress, resulting in a pulling on the endothelium via PECAM 
and Integrin dependent mechanisms[50].  This stress promotes the polarization of 
endothelial cells and their alignment in the direction of blood flow.  The effects of 
shear stress can be clearly observed in the area where the endothelial cells are 
exposed to disturbed flow.  In areas of disturbed or turbulent flow, endothelial cells 
fail to align and are prone to atherosclerotic lesions[51].  Molecularly, this is 
characterized by changes in endothelial Nitric Oxide Synthase (eNOS) activity, 
integrin activation, and alignment of stress fibers[52, 53].  Though the biological 
mechanism of this response remains elusive, the significance of it has been 
demonstrated in its involvement in atherosclerosis and inflammation (Figure 1.2B).   
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Multiple recent reports have documented the role of blood flow in regulation of 
the hematopoietic system.  Loss of blood flow in zebrafish impairs hematopoietic 
development, resulting in decreased cmyb and runx1 expression.  In experiments 
where blood flow was blocked via morpholino knockdown of the cardiac Troponin 
Type 2 (tnnt2) gene, decreased cmyb expression was observed in all hematopoietic 
tissue observed[47].  This approach is limited in that it cannot distinguish between 
effects on hematopoietic specification and hematopoietic maintenance.  If HSCs 
were correctly specified but quickly recruited to downstream cmyb- compartments, 
these experiments would yield the same result.  However, from these studies, it is 
clear that blood flow is providing some biological regulation of the HSC 
compartment.  Additionally, it has been shown that exposure of FACS sorted HSCs 
increases HSC marker expression, such as cmyb and runx1[54].  The mechanism 
by which this regulation occurs is almost completely unknown, though it is presumed 
that it would be similar to the mechanisms observed already in endothelial cells. 
 
Hemogenic Endothelium 
In 1926, Florence Sabin and Charles Doan noted the appearance of apparent 
endothelial cells derivatives in the blood[3].  These cells were seen nearly constant 
and could be considered a normal constituent of the blood.  Though they could not 
know the significance of these cells, they hypothesized that they were upregulated 
during pathogenic conditions.  The possibility that endothelial cells could produce 
hematopoietic cells has persisted.  In 2008, Iruela-Arispe’s group undertook 
extensive lineage tracing experiments using VE-Cadherin:Cre mice and observed 
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that endothelial cells in the dorsal aorta of mice appeared to be ‘budding’ into the 
lumen of the vessel[55].  This was direct evidence that endothelial cells were 
capable of producing non-endothelial, blood components.  
Since those studies, multiple reports have furthered our understanding of the 
hemogenic endothelium.  Hemogenic endothelial cells have been shown to express 
c-myb, runx1, and c-kit[56].  Runx1 has been shown to be required transiently for the 
actual budding, but not to be required for the maintenance of the HSC population 
once it is specified[26, 57].  Recently, direct imaging experiments have shown 
budding of c-myb positive progenitors from the dorsal aorta of both zebrafish and 
mice[6].  It is now a broadly accepted phenomenon that endothelial cells are capable 
of producing HSCs and that these HSCs will contribute to hematopoiesis for the life-
span of the organism.  Currently, one question that remains in the field is the extent 
to which all endothelial cells are hemogenic.  Most studies have focused on the 
aorta as the site of hemogenic endothelium, but given that definitive hematopoiesis 
is observed in non-embryonic tissues, it is possible that other vascular populations 
retain hemogenic ability[58, 59] (Figure 1.2C). 
 
The Caudal Hematopoeitic Niche 
The common ties between hematopoietic and endothelial cells are especially 
interesting when considering the hematovascular niche, which consist of 
hematopoietic stem cells surrounded by a vascular bed.  HSCs must migrate 
through the endothelial layer during the process of differentiation to their 
downstream lineages[21].  The signaling cues which regulate this process, such as 
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blood flow, would be received from the lumen of the vessel.  Thus, it seems that 
direct communication of the endothelial and hematopoietic cells would be necessary 
to coordinate HSC recruitment.  Given the common signaling pathways between 
endothelial and hematopoietic lineages, it would be likely that the signaling cues 
controlling this process in the HSCs also affect the endothelium, and that the 
responses are coordinated and synergistic.  Dysfunction in the niche can result in 
skewed populations or dysfunctional components (T-cells that don’t fight infection).  
Within the series of vascular niches colonized by HSCs in the zebrafish, the 
caudal hematopoietic niche is of particular interest (Figure 1.3).  By 24hpf, the 
zebrafish has a contracting heart, driving blood flow through the vascular system[15, 
17].  In the caudal tissue of the embryo, an aorta carries blood away from the heart 
and a single vein returns blood flow to the heart.  However, starting about 24hpf, the 
vein of the caudal tissue begins BMP-driven sprouting angiogenesis[20].  
Remodeling of the vein in this tissue drives the formation of a second vein and the 
initial vein, now termed the dorsal vein, constricts.  At the same time this caudal vein 
plexus (CVP) is remodeling, HSCs are colonizing the tissue previously occupied by 
the dorsal vein.  By 72hpf, the dorsal vein is almost completely constricted, 
permitting little blood flow, the ventral vein is the primary conduit of blood flow, and 
HSCs have robustly populated the tissue.  Though the colonization by HSCs occurs 
concurrently with the venous remodeling, little is known about the relationship 
between the two processes and whether hematopoietic colonization could occur in 
the absence of the venous remodeling.  Interestingly, blood flow has been shown to 
regulate both the hematopoietic development of the CHT and vascular 
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remodeling[47].  In the absence of blood flow, cmyb fails to be expressed in the 
CHT, and while the sprouting from the vein occurs, the dorsal vein fails to constrict, 
and both veins dilate to such an extent that it appears as one large vessel occupying 
the CHT[47] (unpublished data).  The failure of the dorsal vein to constrict and the 
concurrent venous dilation has confounded attempts to understand the role of blood 
flow in regulation of this remodeling process.  What is clear is that in the absence of 
blood flow, vascular remodeling is aberrant and HSC colonization does not occur, 
further strengthening the ties between these two processes. 
In this thesis, I present evidence that non-aortic endothelial cells can also 
serve as hemogenic sources for HSCs.  Specifically, I show that venous endothelial 
cells within the zebrafish CHT can be hemogenic.  This suggests that hemogenic 
ability may be a more general property of endothelial cells than previously 
appreciated.  Furthermore, I show that HSCs are responsive to blood flow, even 
after the development of the niche.  This indicates that blood flow is a regulator, not 
merely of hematopoietic development, but of the hematopoietic niche.  Finally, I 
identify a PECAM1-like molecule in zebrafish as a potential mediator of this 
response.  Together, these findings increase our understanding of the endothelial 
identity, and the potential role of PECAM1 in hematopoietic regulation.  The need for 
careful term definition in vascular biology occurs because both blood and endothelial 
lineages can be diverse in nature, markers, and function.  For the purposes of this 
report, hematopoietic cells will refer to hematopoietic stem cells capable of self-
renewel and producing the major blood lineages, while endothelial cells will be 
vascular cells lining the lumen of blood-carrying vessels.   
- 13 - 
 
FIGURES 
Figure 1.1:  Concurrent development of the hematopoietic and vascular 
systems. 
   
The hematopoietic and vascular systems develop alongside each other, both 
concurrently (A) and spatially (B).  Prior to one day post fertilization, vascular (vasc) 
patterning is occurring during primitive hematopoiesis (hem) development.  After one 
day post fertilization, the Caudal Hematopoietic Tissue (CHT) is remodeling, while 
definitive hematopoiesis is occurring the the Aorta-Gonad-Mesonephros (AGM) and 
CHT.  
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Figure 1.2:  Common hematovascular ties.   
 
Endothelial and hematopoietic cells have many common ties.  They can be specified 
by a common progenitor, termed the hemangioblast (purple cells in A).  They share 
many of the same niches and signaling cues, such as Notch and blood flow in the 
Aorta-Gonad-Mesonephros (AGM) and BMPs and blood flow in the Caudal 
Hematopoietic Tissue (CHT), (B).  Certain endothelial cells, hemogenic endothelium 
(green cell in C) can produce hematpoietic stem cells. 
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Figure 1.3:  The caudal hematopoietic niche.   
 
 
The caudal hematopoietic niche is both a site of hematopoietic development and 
vascular remodeling.  A confocal micrograph of a Tg(cmyb:GFP;kdrl:mCherry) 
embryo is shown (A) with a budding c-myb+ progenitor (arrow).  A schematic 
representation of this specialized niche is shown (B).  Cmyb+/kdrl+ cells are shown 
as yellow, while cmyb+/kdrl- cells are shown as green. 
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CHAPTER 2 
Hematopoietic Potential of Venous Endothelial Cells1 
 
OVERVIEW 
Since 1926, the existence of blood-producing endothelial cells has been 
suggested by scientific investigation[1].  These cells have been termed hemogenic 
endothelial cells--endothelial cells capable of producing the hematopoietic stem cells 
responsible for all hematopoietic lineages.  Current evidence suggests that this 
ability is limited to a specialized subset of endothelial cells, residing in particular 
niches[1-5].  In this study, we identify the zebrafish Caudal Hematopoietic Tissue 
(CHT) as a vascular bed capable of producing hematopoietic stem cells (HSCs).  
We examined the co-expression of hematopoietic and venous markers within the 
zebrafish cardinal vein during development, using in situ, immunofluorescence, and 
time-lapse imaging.  We found that venous endothelial cells in the cardinal vein co-
expressed hematopoietic markers, that these cells were capable of budding to 
produce hematopoietic progenitors, and though most previously identified 
hemogenic vascular beds have been arterial, we find that hemogenic venous 
endothelial cells also exist and are present throughout development.  We also find 
that blood flow exerts not only a developmental effect, but that it regulates these 
cells beyond specification of the cell type.   
1 Assistance was provided with Dab2 immunofluorescence by Jun-Dae Kim.  
Caroline Burns, Yong Zhou, and Neal Chi provided key reagents. 
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INTRODUCTION 
The hematopoietic and vascular systems share several extensive ties 
throughout development, such that they can be collectively referred to as the 
hematovascular system.  The relationship between these two systems is complex 
and intricate, involving common progenitors, similar signaling pathways, and multiple 
molecular switches between the two lineages.  Additionally, transitions between the 
two systems appears to be possible in the existence of hemogenic endothelium—
specialized endothelial cells which retain the ability to produce hematopoietic stem 
and progenitor cells (HSCs/HPCs)[2, 4-15].  Hemogenic endothelial cells reside 
precisely at the intersection of the hematopoietic and vascular systems.  The 
possible existence of hemogenic endothelium was first documented in 1926 by 
Florence Sabin and Charles Doan, who noticed that endothelial cells occasionally 
appeared in the blood of certain individuals[1].  Further studies since then have 
elucidated molecular markers of these endothelial cells, such as c-myb, runt-related 
transcription factor 1 (runx1), Vascular Endothelial Cadherin (VE-Cadherin), and 
more recently, c-kit[16].  It has also become clear, that in vivo, not all endothelial 
cells are hemogenic at the same time.  Multiple lines of evidence have indicated that 
the dorsal aorta is a site of definitive hematopoiesis, and given the importance of this 
region, many of investigations into hemogenic endothelium have focused on the 
aorta-gonad-mesonephros (AGM) as an early site of definitive hematopoiesis and 
hemogenic endothelium.  Others have identified other sites of hematopoiesis, such 
as the placenta, the yolk sac, and the vitelline and umbilical arteries[17-23].  Though, 
these investigations have revealed that the AGM is not the only source of 
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hemogenic endothelium, whenever examined, the hemogenic endothelium was 
arterial in nature.  As hematopoiesis appears to be a migratory process, colonizing 
several distinct niches temporarily before finally settling in the mammalian bone 
marrow or the teleost kidney, we sought to determine if these different niches were 
capable of producing their own hemogenic endothelium, or if each niche was 
sequentially colonized by a migrating population, all arising from the same initial 
niche. The implications that defects in the hematopoietic system could be regulated, 
impacted, or resolved by modulation of endothelial signaling has huge clinical 
relevance in the treatment of hematopoietic disorders, transplant rejections, etc.   
Though the ability of endothelial cells to produce hematopoietic progenitors 
has been well documented across multiple species, the nature of this process 
remains unclear, and multiple studies have focuses on determining the sites of 
hemogenic endothelial cells.  Here, we expand upon existing knowledge about 
hemogenic endothelium and show for the first time, that a non-arterial vascular bed 
retains the ability to become hemogenic.  Further, we elucidate the regulation of 
these venous hemogenic endothelial cells by blood flow, a common regulator of both 
hematopoietic and vascular cells. 
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EXPERIMENTAL PROCEDURES 
Zebrafish husbandry, microinjection, and immunohistochemistry 
Zebrafish were maintained according to IACCUC-approved protocols. The 
following transgenic lines were used: Tg(kdrl:ras-mCherry)s896, Tg(cmyb:GFP)zf169, 
Tg(ubb:LoxP-AmCyan-LoxP-ZsYellow)fb5, and Tg(ubb:loxP-EGFP-loxP-
mCherry)cz1701. 
Embryos were injected into the yolk sac at the one-cell stage as previously 
described[24]. To block heart beat, cardiac Troponin Type 2 (tnnt2) MO was used 
(5- CATGTTTGCTCTGATCTGACACGCA-3’)[25]. Immunohistochemistry were 
performed as previously described[26], using mouse anti-Disabled homolog 2 
(Dab2) antibody (Abcam, 1:500). 
 
FACS Analysis and qRT-PCR 
28hpf Tg(kdrl:ras-mCherry)s896;Tg(cmyb:GFP)zf169 embryos were dissociated 
using liberase at 37°C. Subsequently, suspension of dissociated cells were sorted 
on a Fluorescence-activated cell sorting (FACS) Aria. Four distnict populations of 
cells (GFP-/mCherry-, GFP-/mCherry+, GFP+/mCherry- and GFP+/mCherry+) were 
collected and RNA was extracted to perform qRT-PCR to determine their molecular 
identities. 
For qRT-PCR, the following primers were used:  
cmyb-f, TCCCGGCTCCATCCCTAGAGC; cmyb-r 
TTGTTGGCCCAGACTGATGGGG; c-kit-f, ACAAGTGCGCTGTGTGGCCG; c-kit-r, 
GGCTCTCCACTGCGCCTTTCC; runx1-f, CGCTGAGCTCCGCAACGCTA; runx1-r, 
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ATCCGGCTTCTGTCGGTGGC; gata1a-f,  CGAGATGGGACAGGCCACTACCT; 
gata1a-r, GCAGTTGGCGCACTGCGTTC; 18s-f, cacttgtccctctaagaagttgca; 18s-r, 
ggttgattccgataacgaacga; b-actin-f, AAGCTGTGACCCACCTCACGC; b-actin-r, 
TCAACGACCAGGGCAGCGATT. 
 
Image acquisition, quantification and statistical analyses 
For time lapse imaging, wild-type embryos were anesthetized in 640μM of 
tricaine methanesulfonate (Tricane) and embedded on glass-bottom dishes in 1% 
low-melt agarose dissolved in Tricaine and embryo medium (1mM NaCl). 
Subsequently, embryos were imaged on a Zeiss 710 two-photon microscope for 12 
hours at 4 minute intervals starting at 24hpf. For lineage tracing, spectral imaging 
using Zeiss 510 with Meta-detection was performed. The acquired images were 
analyzed using Volocity. 
To quantify cmyb+ cells contained within the CVP, embryos were imaged at 
40x magnifications through the caudal vascular plexus (CVP) starting at the end of 
the yolk extension (approximately correlating to somites 16-20). Individual z-slices 
were exported to Photoshop, and GFP expression (labeled by cmyb:GFP transgene) 
which persisted for at least three z-slices (approx. 30μm) was defined as a cmyb+ 
cell. Individual cmyb+ cells were numbered and then assessed for mCherry 
expression (labeled by kdrl:mCherry transgene). At least ten embryos per condition 
were examined to provide statistical analyses. 
To assess the distribution of cmyb+ cells within the CVP, a cartograph was 
generated by tracing all cmyb+/kdrl- and cmyb+/kdrl+ cells within the CVP of each 
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24hpf or 72hpf embryo. These individual cartographs were overlayed onto a single 
composite, which was divided into five segments, corresponding to somites. 
To determine the statistical significance of differences between percentages of 
cmyb+/kdrl+ cells in control and tnnt2 MO injected embryos, one-tailed, student t-
tests were performed. 
 
Chemical Treatment 
(2,3)-Butanediomemonoxime (BDM) and epinephrine(EPI) were obtained 
from Sigma Aldrich.  Starting at either 67hpf or 69.5hpf, zebrafish embryos were 
treated for either 5 hours or 2.5 hours, respectively, with BDM or epinephrine.  For 
BDM treatments, embryos were pulsed with 30uM BDM to cause cessation of the 
heartbeat and then maintained in 25uM BDM for the duration of the experiment.  For 
epinephrine treatments, embryos were maintained in 10ug/mL epinephrine for the 
duration of the experiment.  Both drugs were dissolved directly in egg water to 
permit the use of egg water as the control treatment. 
 
Plasmid construction and transient lineage tracing 
To perform transient lineage tracing, kdrl:Cre-ERt2 construct was generated 
by subcloning Cre-ERt2 under the regulation of the kdrl promoter in a Tol2 based 
vector[26-28]. To generate somatic mosaicism, 
Tg(cmyb:EGFP)zf169;Tg(kdrl:mCherry)s896 double transgenic individuals were crossed 
with Tg(ubb:LoxP-AmCyan-LoxP-ZsYellow)fb5 transgenic individual. The resulting 
embryos were co-injected at the one-cell stage with transposase mRNA and 
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kdrl:Cre-ERt2. Embryos were reared at 28°C and treated with 4μM tamoxifen from 18 
to 24hpf as previously described, and analyzed at 36 and 48hpf.[29]  Similarly, 
embryos were treated 4μM tamoxifen from 66hpf to 72hpf and imaged at 84hpf and 
96hpf.  
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RESULTS 
Venous endothelial cells express hematopoietic markers 
Using transgenic zebrafish expressing GFP under control of the 
hematopoietic stem cell marker, cmyb, and mCherry under control of the kdrl 
promoter, we first sought to determine whether non aortic endothelial cells could 
express hematopoietic markers during development.  The Caudal Vein Plexus 
(CVP) of Tg(cmyb:EGFP)zf169;Tg(kdrl:mCherry)s896 zebrafish embryos was examined 
by confocal microscopy at 24hpf (Figure 2.1A).  HSCs were detected of two 
fluorescent profiles, cmyb+/kdrl+ and cmyb+/kdr- cells (GPF+/mCherry+ and 
GFP+/mCherry-, respectively).  As nascent hematopoietic progenitors quickly lose 
the expression of vascular genes after delamination, the cmyb+/kdrl+ population 
likely represents a population originating from endothelial cells within the CVP 
(Figure 1.1A).[5, 30]  Given that the caudal hematopoietic tissue (CHT) is a later 
developing niche, we hypothesized that, if it had hemogenic activity, there would be 
nascent hematopoietic progenitors present later in development.  To examine this 
possibility, the cardinal vein of zebrafish was imaged at different points in 
development.  Double transgenic zebrafish Tg(kdrl:mCherry);Tg(cmyb:GFP) 
embryos were imaged at 24hpf and 72hpf.  At all timepoints examined, cmyb 
expression could be detected within venous cells of the zebrafish caudal 
hematopoietic tissue (Figure 2.1A, B).  At 24hpf, an average of six cells within the 
wall of the caudal vein were cmyb+/kdrl+ (n=10, s=4) (Figure 2.1C). The number of 
cmyb+/kdrl+ cells significantly increased to an average of 12 cells (n=10, s=7) by 
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72hpf (Figure 2.1C).  This indicates that this population of cells is present through 
the development and patterning of this endothelial niche.   
To further substantiate that cmyb expression was within the endothelial cells 
population, embryos were dissociated and cell populations were assessed via 
Fluorescence Activated Cell Sorting (FACS) analysis.  
Tg(kdrl:mCherry);Tg(cmyb:GFP) embryos at 28hpf and 72hpf were dissociated and 
analyzed by sorting on a FACS Diva.  In the total embryo at 28hpf, cmyb+ 
endothelial cells were 20 percent of the endothelial population.  Consistent with 
confocal results, this population was maintained as a percentage of total endothelial 
cells (Figure 2.1E).  At 72hpf, cmyb+ endothelial cells were 7% of the total 
endothelial population (Figure 2.1E).  However, when only the CHT was used for 
dissociation, cmyb+ endothelial cells were 19 and 21 percent of the kdrl+ population 
at 24hpf and 72hpf, respectively, confirming that a kdrl+/cmyb+ population of 
endothelial cells is present within the zebrafish CHT cells throughout development 
(Figure 2.1E).  Together, this data shows that cmyb is expressed in a subset of 
endothelial cells within venous endothelial cells of the zebrafish CHT and that this 
population of cells persists later into development than previously reported.  FACS 
analysis corroborated our finding that CVP contains cmyb+/kdrl+ cells both before 
and after the proposed colonization of the AGM-derived hematopoietic progenitors 
(Figure 2.1E).  Taken together, the data support that the cmyb+/kdrl+ population 
persists at 72hpf after the dissolution of the AGM.  
Given that these HSCs were located outside of the typical AGM 
hematopoietic niche, we sought to determine if they were in fact not arterial, but 
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instead venous in nature.  To test this, we examined co-expression of the venous 
marker, Disabled homolog 2 (Dab2), at 36hpf.  To confirm that these endothelial 
cells were venous in nature, embryos were fixed and stained for the venous marker, 
Dab2.  Dab2 expression is restricted to the vein by 36hpf in the developing 
zebrafish.  Transgenic embryos, Tg(cmyb:GFP) were fixed at 36hpf and co-stained 
for GFP and Dab2.  Co-expression of GFP and Dab2 was observed, consistent with 
the live-imaging results and further demonstrating that venous endothelial cells are 
capable of expressing hematopoietic markers (Figure 2.1F).  The cmyb+/kdrl+ cells in 
the CVP strongly expressed venous specific marker, dab2, indicating their venous 
identity (Figure 2.1F).  
To rule out the possibility that the cmyb+/kdrl+ cells within the CVP are the 
previously described GATA-binding factor 1 (gata1)+/pu.1+ erythromyeloid 
progenitors (EMP), we examined the expression of gata1 from the 
isolated cmyb+/kdrl+ cells. [31]  While the expression of cmyb and c-kit were strongly 
detected, the expression of gata1 was not detected in this population, suggesting 
that cmyb+/kdrl+ cells within the CVP are not likely to be the EMPs, but are more 
likely to be HSCS capable of producing all hematopoietic lineages (Figure 2.2). 
 
cmyb+ cells within the zebrafish CHT are located in the wall of the vessel  
To confirm that cmyb+/kdrl+ cells are within the vessel wall, Z axes of each 
confocal image were analyzed (Figure 2.1A, B). Three-dimensional reconstructions 
of the vein confirmed that the observed cmyb expression was within the wall of the 
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vessel, suggesting the ability of venous endothelial cells to become hemogenic 
(Figure 2.3A-D).   
 
cmyb+ progenitors arise de novo in the CHT  
It is known that hematopoietic progenitors bud from the hematopoietic tissue 
of the AGM and enter circulation to colonize other tissues.  To rule out the possibility 
that the cmyb+/kdrl+ cells detected in the CHT were the result of cells budding from 
the AGM, we blocked circulation using a morpholino targeting cardiac Troponin Type 
2 (tnnt2) which would prevent colonization by HSCs from other tissues, such as the 
aorta-gonad-mesonephros (AGM).  We examined whether both cell types could be 
detected in the CHT in the absence of blood flow.  The morpholino targeting tnnt2 
was injected into the one-cell embryos, and embryos were screened at 24hpf.  We 
found that cmyb+/kdrl+ cells could be detected in the tnnt2-MO injected embryos 
(Figure 2.4A-B).  Furthermore, cmyb+/kdlr- cells, which, as previously reported, are 
rapidly depleted in the absence of blood flow, represent a lower percentage of the 
overall population.  cmyb+/kdrl+ cells were 50% and 75% of the total cmyb+ 
population in control and tnnt2-MO injected embryos respectively (Figure 2.4C).  The 
total number of cmyb+/kdrl+ cells actually increased from 4 cells in control injected to 
41 cells in tnnt2-MO injected embryos (Figure 2.4D).  The reason for this transient 
increase is not yet clear.  As previously reported, the majority of cmyb+/kdr- cells are 
lost in the absence of flow.  It remains a possibility that blood flow required for the 
controlled regulation of these cell subtypes.   We found that in the absence of 
circulation, as previously reported, cells from the AGM do not colonize the CHT.  
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However, cmyb expression could still be detected within the endothelial cells of the 
CHT.  Due to the lack of additional progenitors from the AGM, most of the cmyb+ 
cells observed were positive for kdrl, suggesting that they are new progenitors, just 
being derived from the endothelial cells in the CHT. 
 
cmyb+/kdrl+ progenitors preferentially localize in the CHT 
We next investigated whether cmyb+/kdrl+ cells in the CHT had a 
preferentially localization in this niche.  To examine the spatiotemporal pattern of 
cmyb+/kdrl- and cmyb+/kdrl+ within the CVP, we generated cartographs at 24 and 
72hpf and placed the localization of cmyb+/kdrl+ and cmyb+/kdrl- cells onto each 
cartograph at 24hpf or 3dpf as appropriate.  We found that at 24hpf, the cmyb+/kdrl+ 
cells were preferentially located in the anterior regions of the CHT (Figure 2.5A, C).  
While the cmyb+/kdrl- and cmyb+/kdrl+ cells are clustered anteriorly at 24hpf (Figure 
2.5A, C), they become more dispersed within the CVP (n=10) at 72hpf (Figure 2.5B, 
D).   
The distribution of HSCs within the different vessels of the CVP was also 
examined.  Interestingly, the dorsal wall of the cardinal vein and the dorsal wall of 
the dorsal vein were the most prominent sites to detect cmyb+/kdrl+ cells—41% of 
cmyb+/kdrl+ cells resided in association with these surfaces at either 24hpf or 72hpf 
(Figure 2.5E, F).  That this percentage was constant at 24hpf and 3dpf suggests a 
stable characteristic of the dorsal vein. 
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cmyb+ cells within the CHT bud from the endothelium. 
 To confirm that hematopoietic progenitors arise directly from venous 
endothelial cells of the CHT, we performed time-lapse imaging.  Fish were 
immobilized in agarose and imaged for 12 hours beginning at 24hpf.  cmyb+/kdrl+ 
cells could be observed to bud from the dorsal vein (Figure 2.7, 2.8).  This budding 
was abluminal in nature and was sometimes followed by the nascent progenitor 
entering circulation.  Interestingly, this is at the same time which this tissue is 
remodeling and the dorsal vein of the cardinal tissue is constricting, suggesting a 
possible fate for the endothelial cells of the dorsal vein.  To exclude the possibility 
that the cmyb+ cell migrates and is incorporated into the vessel wall within the area 
of observation, we analyzed the z-slices 20μm above and below the forming 
cmyb+/kdrl+ cell (Figure 2.8A). We found that kdrl+ cells within the wall of vein initiate 
the expression of cmyb, and a subset of these cells subsequently delaminate from 
the vessel wall and enter into the circulation (Figure 2.7, 2.8), suggesting that 
cmyb+/kdrl+ cells in the CVP undergo similar transition as those in the dorsal aorta.   
To further delineate the ontogeny of the cmyb+/kdrl+ cells in the CVP, we 
examined performed short-term lineage tracing (Figure 2.9).  cmyb+/kdrl+ cells were 
observed to lose kdrl expression and produce cmyb+/kdrl- cells.  Thus, single cell 
lineage tracing supports that these venous endothelial cells can differentiate as 
hemogenic endothelium and eventually contribute to the hematopoietic progenitor 
population, suggesting that hemogenic potential is not restricted to only arterial 
endothelial cells (Figure 2.9).   
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cmyb+ cells within the CHT display unique behaviors 
We performed time-lapse imaging of the tissue to observe the behavior of 
these cmyb+/kdrl+ cells.  While the majority of the cmyb+/kdrl+ cells within the CVP 
maintain stereotypic endothelial morphology, time-lapse imaging revealed dynamic 
behavior of these cells.  HSCs within the vessel wall were capable of proliferating 
(Figure 2.10A), and a subset of cells occasionally protruded toward the luminal side 
of the vein and buds off from the vein wall (Figure 2.10B), as observed in the AGM 
region.  We found that cmyb+/kdrl+ cells within the dorsal vein were capable of 
proliferating within the wall of the vessel with a cell division perpendicular to the 
vessel lumen (Figure 2.10A).  Furthermore, these cells were capable of protruding 
into the vessel lumen, and a diverse range of migratory behaviors, including crawling 
along the vessel, or rolling in circulation (Figure 2.10B).  Together, this suggests that 
the behavior of these cells is dynamic and exposes them to a wide variety of 
environments within the niche. 
 
cmyb+/kdrl+ cells respond distinctly to the loss of blood flow   
Previous reports have shown that blood flow acts as a regulator for both 
endothelial and hematopoietic cells.  Interestingly, no reports have specifically 
addressed the effect of blood flow on hemogenic endothelium.  We investigated by 
confocal microscopy the ability of blood flow to regulate the hemogenic endothelium 
within the zebrafish CHT.  To eliminate possible effects on development of the 
hematopoietic tissue, embryos were raised to 68hpf.  Definitive hematopoiesis 
begins at 24hpf, with highest detectable activity at 36-48hpf.  By waiting until 68hpf, 
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we hoped to only observe effects on the hemogenic endothelium of the CHT.  At 
68hpf, embryos were incubated in either BDM or epinephrine, to either block or 
increase blood flow, respectively.  We found that blood flow tightly regulated cmyb 
expression within the CHT.  We found that BDM treatment resulted in the rapid 
depletion of cmyb expression within the CHT.  By 5hr of BDM treatment, both the 
number of cmyb+ cells and the expression levels had decreased.  By contrast, 
stimulation of blood flow by epinephrine had the opposite effect, and increased cmyb 
expression could be detected (Figure 2.11). Loss of blood flow resulted in loss of the 
cmyb expression, while increased blood flow, as caused in the epinephrine 
treatment, caused increased cmyb expression (Figure 2.11). 
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DISCUSSION 
To our knowledge, this is the first detailed study of a non-aortic bed of 
hemogenic endothelium.  We demonstrate that endothelial cells outside of the AGM 
are capable of producing cmyb+ progenitors, that these cells can be venous in 
nature, and that they respond distinctly to changes in blood flow.  Previous reports 
had focused on the dorsal aorta as a site of hemogenic endothelium.  Because of 
this, these studies have not been able to elucidate the ability of all endothelium to 
become hemogenic.  Though our study falls short of demonstrating that 
hematopoietic potential is an intrinsic property of most endothelial cells, we broaden 
the scope of hemogenicity in endothelial cells by examining that property in venous 
endothelial cells.  Furthermore, we demonstrate the ability of blood flow to regulate 
hematopoietic potential of endothelial cells.  Though flow has been implicated in the 
development of hematopoietic niches and specification of hematopoietic stem cells, 
this is the first report that demonstrates that blood flow is a regulator of the HSCs 
post-development.  
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FIGURES 
Figure 2.1:  Detection of cmyb in venous endothelial cells throughout 
development.   
 
Tg(cmyb:GFP;kdrl:mCherry) embryos were imaged by confocal microscopy for the 
existence of co-postive cells within the vessel wall at 24hpf (A) and 72hpf (B).  The 
number of cmyb+ cells within the vessel wall is quantified (C) as is the total number 
of cmyb+ progenitors within the CHT (D).  FACS analysis was done on embryos or 
CHTs of 28hpf and 72hpf embryos to determine if co-positive progenitors were 
detected (G). Tg(cmyb:GFP) embryos were fixed at 36hpf and stained for the 
venous marker, Dab2 (F).  
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Figure 2.2  cmyb+/kdrl+ cells express hematopoietic markers. 
 
Endothelial cells were sorted for Tg(cmyb:GFP) expression.  FACS sorted cells were 
subjected to QPCR for c-kit, cmyb, and gata1. 
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Figure 2.3  Detection of cmyb within the venous vessel wall. 
 
Three-dimensional reconstructions were created of cmyb:GFP+ cells within the 
vessel wall of 24hpf (A-B) and 72hpf (C-D) embryos. 
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Figure 2.4  cmyb+ endothelial cells arise de novo from the cardinal 
vein. 
 
Tg(cmyb:GFP;kdrl:mCherry) double transgenics were examined by confocal 
microscopy.  Control embryos (A) and tnnt2-MO injected embryos (B) both showed 
cmyb+/kdrl+ double positive cells at 24hpf.  The results are quantified by number of 
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Figure 2.5:  Preferential distribution of cmyb+ endothelial cells.  
 
The location of cmyb+/kdrl+ and cmyb+/kdrl- cells was plotted on detailed 
cartographs.  Representative cartographs are shown for 24hpf (A) and 72hpf (B).  
The distribution anterior to posterior is quantified for 24hpf (C) and 72hpf (D).  The 
distribution of arterial versus venous associations is quantified for 24hpf (E) and 
72hpf (F).   
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Figure 2.6  Cartographs reveal preferential localization of cmyb+ endothelial 
cells.  
 
The location of cmyb+/kdrl+ and cmyb+/kdrl- cells was plotted on detailed 
cartographs.  Nine cartographs are shown for 24hpf (A) and 72hpf (B).   
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Figure 2.7 cmyb+ endothelial cells bud from the vascular wall. 
 
Tg(cmyb:GFP,kdrl:mCherry) double transgenic embryos were examined by time-
lapse confocal microscopy.  Cells were observed to bud (arrow) and exit the vessel 
(asterisk). 
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Figure 2.8:  cmyb+ endothelial cells bud from the vascular wall and enter 
circulation. 
 
Tg(cmyb:GFP,kdrl:mCherry) double transgenic embryos were examined by time-
lapse confocal microscopy.  A schematic of the z-slices is shown (A).  Cells were 







- 45 - 
 
Figure 2.9:  cmyb+/kdrl+ cells give rise to cmyb+/kdrl- cells. 
 
Tg(ubb:LoxP-AmCyan-LoxP-ZsYellow);Tg(kdrl:mcherry);Tg(cmyb:GFP) embryos 
were injected with kdrl:CreERt2 plasmid.  The experimental design is diagrammed 
(A).  The injected embryos were treated with tamoxifen for six hours and imaged by 
confocal microscopy (B). 
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Figure 2.10:  cmyb+ endothelial cells proliferate and migrate in the CHT. 
 
Tg(cmyb:GFP,kdrl:mCherry) double transgenic embryos were examined by time-
lapse confocal microscopy.  Cells were observed to undergo mitosis (A), budding 
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Figure 2.11:  Blood flow regulates venous hemogenic endothelium. 
 
Tg(cmyb:GFP;kdrl:mCherry) double transgenic embryos were treated for 5 hours 
with vehicle, (2,3)-BDM, or epinephrine at 67 hpf.  Embryos were examined at 72hpf 
by confocal microscopy (A).  RNA was extracted on used to perform QPCR of 
hematopoietic (B) or vascular (C) genes.  
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CHAPTER 3 




Both the hematopoietic and vascular systems have flow-sensitive 
mechanisms of development.  In endothelial cells, multiple aspects of the response 
to blood flow have been shown to be regulated by the association of including 
Platelet Endothelial Cell Adhesion Molecule-1 (PECAM1) with Vascular Endothelial 
Cadherin (VE-Cadherin).  This association has been shown to be induced in 
response to blood flow and triggers activation of endothelial Nitric Oxide Synthase 
(eNOS) and an alignment of endothelial cells in the direction of blood flow.  In this 
report, we sought to identify a zebrafish homolog of PECAM1 and to investigate a 
potential role of PECAM1 in hematopoietic development.  We find that the zebrafish 
gene XP_697859.3 has homology with mammalian PECAM1, has a vascular 
expression profile, and that loss of XP_697859.3 has hematopoietic and va 
remodeling defects, consistent with a role for PECAM in hematopoietic and vascular 
function. 
INTRODUCTION 
The response of endothelial cells to blood flow is an area of intense 
investigation.  It has been shown to include alignment of endothelial cells in the 
direction of blood flow, increased endothelial Nitric Oxide Synthase (eNOS) activity, 
and Krueppel-like factor 2 (klf2) regulation[1-6].  Within the organisms, there are two 
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types of blood flow, depending on the nature of the vessel.  Elongated, straight 
vessels experience a constant, uniform blood flow, termed laminar flow.  Endothelial 
cells in areas of the vessel where bifurcations or turns occur experience a less 
uniform flow, where blood can be pushed in different directions as the vessel turns.  
This is termed turbulent or disturbed flow.   
The importance of this response is shown in susceptibility to atherosclerosis.  
Areas of the endothelium under sustained laminar flow, align, polarize, and are less 
prone to develop atherscolerotic lesions.  Alternatively, areas of the endothelium 
under disturbed or turbulent blood flow do not align and are much more susceptible 
to develop atherosclerotic plaques[7, 8].  Though the initial sensor of blood flow 
remains unidentified and the subject of intense research, one of the mediators of this 
response has been shown to be including Platelet Endothelial Cell Adhesion 
Molecule-1 (PECAM1), which within endothelial cells exposed to blood flow, 
becomes associated with Vascular Endothelial Cadherin (VE-Cadherin) and 
Vascular Endothelial Growth Factor Receptor-2 (VEGFR2, or kdrl in zebrafish) in a 
‘mechanosensory complex.[1]’  Endothelial cells lacking PECAM1 fail to align in the 
direction of blood flow and fail to increase eNos production in response to blood 
flow[1, 3, 4].  Additionally, PECAM1 loss promotes the development of 
atherosclerotic lesions in areas of laminar flow—areas normally protected from the 
development of atherosclerosis[1, 9-11]. 
Interesting, in mammalian systems where PECAM expression is known, it is 
not restricted to endothelial cells, but is also expressed in hematopoietic stem cells 
(HSCs), as is VE-Cadherin[12, 13].  This is given more significance by the discovery 
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that HSCs are also regulated by blood flow.  Exposure of HSCs to blood flow was 
shown to increase expression of hematopoietic stem cell markers[14].  Concurrently, 
it was shown that loss of blood flow in the organism results in loss of HSC 
development, either by lack of specification of lack of adequate maintenance[15].   
Given that both endothelial cells and hematopoietic cells respond to blood 
flow, we hypothesized that PECAM1 or PECAM1-like signaling would mediate this 
flow response in hematopoietic, as well as endothelial, cells in the zebrafish.  We 
investigated this possibility by first identifying a zebrafish homolog of PECAM1, 
characterizing its expression in development, and then examining its role in the 









Zebrafish were maintained according to IACCUC-approved protocols in an 
Aquatic Habitats (AHAB) facility.  The following transgenic lines were used:  
Tg(kdrl:ras-mCherry)s896, Tg(cmyb:GFP)zf169.  Embyros were raised at 28degC until 
the specified timepoints. 
 
Identification of XP_697859.3 
An amino acid blast was performed of mmPECAM1 against all putative open 
reading frames (ORFs) of the zebrafish genome, www.zfin.org .  Reciprocal best hits 
were assessed using the identified best zebrafish hit as a query in the ensemble 
blast against mammalian, both human and mouse, genomes. 
 
Syntenic and Phologenic Analysis 
Syntenic analysis was performed using Cinteny, the server for synteny 
identification and analysis of genome rearrangement, http://cinteny.cchmc.org/ . 
Human chromosome 17, containing PECAM1, and danio rerio chromosome 3, 
containing XP_697859.3, were compared.  A minimum syntenic length of 70kb was 
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In situ hybridization 
In situ analysis was performed as previously described[16].  Briefly, embryos 
at the appropriate timepoint were fixed overnight at 4degC in 4% paraformaldehyde.  
Embryos were dehydrated in methanol overnight at -20degC.  The full-length 
transcript of XP_697859.3 was cloned into pCS2+ and anti-sense, dig-labeled probe 
was synthesized using a Dig-labeling kit, Ambion Cat#1234. 
 
Morpholino Injection 
Embryos were injected into the yolk sac at the one-cell stage as previously 
described[17]. To block heart beat, tnnt2 MO was used (5- 
CATGTTTGCTCTGATCTGACACGCA-3’).  Two morpholinos were used targeting 
XP_697859.3:  MO1 and MO2.  MO1 targeted the start codon.  The sequence of 
MO1 is: (5’-CCGCTCCCATCCTCACAGGTGAA-3’).  MO2 targeted the splice site 
from exon3 to intron3.  The sequence of MO2 is: 
(5’AACGCAGTGTTTCTGCTCACCTGTG-3’).  A standard 1x concentration 
of .4pmol morpholino per embryo was injected.    
 
mRNA Injections 
The coding sequence of XP_697859.3 was cloned into pCS2+.  Capped 
mRNA was synthesized using a SP6 polymerase kit from Ambion.  For rescue, .1ng 
coding mRNA was injected at the one cell stage.  For over-expression analysis, 
either .1ng or .2ng coding mRNA was injected at the one cell stage. 
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RESULTS 
By an amino acid blast of mammalian PECAM1 against all putative open-
reading-frames (ORFs) in the zebrafish genome, we isolated XP_697859.3.  
XP_697859.3 has 35% identity and 40%similarity with mammalian PECAM1 (Figure 
3.1A).  When blasted against the mammalian genome, XP-697859.3 showed the 
highest similarity to PECAM1.  To further investigate the evolutionary relationship 
between these two genes, the chromosomes containing each of them was 
compared using syntenic alignment (Figure 3.1B).  Though there is a break in 
synteny right at the XP_697859.3 locus, the chromosome including XP_697859.3 is 
syntenic to the mammalian chromosome including PECAM1 at multiple other loci, 
spaced throughout the chromosomes.  When phylogenic analysis was performed 
using the mouse, frog, and zebrafish potential homologs, the zebrafish gene was the 
most diverged from the mouse gene (Figure 3.1C).  Taken together, this suggests 
that though the amino acid sequences show some homology, and they are likely 
descendents from the same ancestral gene, the DNA sequence in teleosts has 
diverged significantly from that in mammalian systems, and demonstration of their 
relationship will require functional conservation. 
To further determine if XP_697859.3 is a functional homolog of PECAM1, we 
characterized its expression by RT-PCR and in situ hybridization.  RNA was 
extracted from embryos at 3 hours post fertilization (hpf), 18hpf, 24hpf, 3 days post 
fertilization (dpf), and one week.  XP_697859.3 was detectable by RT-PCR starting 
at 18hpf.  Expression increased until 72hpf and was still present at one week (Figure 
3.2E).  This expression profile is consistent with a vascular gene, as vascular 
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patterning begins just prior to 18hpf.  VE-Cadherin and VegfR2 have similar 
expression profiles[18, 19].  RT-PCR of XP_697859.3 in cloche, a mutant lacking 
both endothelial and hematopoietic cells, showed loss of XP_697859.3 expression in 
the cloche background (Figure 3.2F).  In wild-type embryos, in situ hybridization of 
XP_697859.3 showed a vascular pattern at 24hpf and 48hpf (Figure 3.2A-D).  
Interesting at 48hpf, by in situ, XP_697859.3 expression appeared to be increased 
within the caudal vein plexus (CVP)—a vascular and hematopoietic niche, 
undergoing extensive remodeling at that timepoint (Figure 3.2 B, D).  To further 
determine the endothelial expression of XP_697859.3, QPCR of sorted endothelial 
cells was performed.  Briefly, Tg(cmyb:GFP);Tg(kdrl:mCherry) embryos were 
dissociated and sorted for GFP or mCherry expression.  A 15-fold induction was 
seen in the endothelial (mCherry+/GFP-) specific population only (Figure 3.2 G).  
This is similar to the expected fold change for known endothelial markers (kdrl).  In 
situ analysis of XP_697859.3 expression in the avascular mutants, cloche and 
groom of cloche, both of which lack endothelial cells, though groom of cloche retains 
hematopoietic cells, was not as informative.  Though XP_697859.3 expression 
appeared reduced in cloche, groom of cloche appeared to express higher levels of 
XP_697859.3, either due to the presence of hematopoietic cells, the remnants of 
some endothelial cells, or increased background expression (data not shown). 
To further determine the function of XP_697859.3, we designed two 
morpholinos.  Morpholino 1 (MO1) targeted the start codon of XP_697859.3 while 
morpholino 2 (MO2) targeted the splice site of exon 2-intron 2, potentially resulting in 
incorporation of intron 2, and 9 termination codons.  As MO1 blocks the ATG start 
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site of the transcript, it is anticipated that it should block all translation of the 
XP_697859.3 gene, resulting in loss of most, if not all protein, from this transcript.  
To determine if XP_697859.3 was involved in a flow response, it was injected 
alongside a morpholinos targeting cardiac troponin, tnnt2.  Tnnt2 is expressed 
specifically in cardiac muscle, and when silenced using a morpholinos, results in 
specific lack of a beating heart.  Development is unperturbed and vascular 
patterning is retained, but the heart fails to contract and the endothelial cells are 
never exposed to blood flow.  This has become a useful tool to understanding the 
effects of blood flow on the vascular system.  As previously reported, loss of tnnt2 
resulted in dilation of the cardinal vein, and failure of hematopoietic cells to colonize 
the tissue.  To test the role of XP_697859.3 in these same processes, MO1 was 
injected into Tg(cmyb:GFP);Tg(kdrl:mCherry) embryos, and the embryos were 
screened at 36hpf.  When injected at the 1x concentration, MO1 recapitulates the 
tnnt-morpholino injections.  The cardinal vein is dilated, indicated a failure of the 
tissue to remodel, and decreased cmyb expression is detected in the CHT (Figure 
3.3A).  This phenotype could be rescued by co-injection of wild-type mRNA, 
indicating that it is the result of specific targeting of the XP_697859.3 transcript 
(Figure 3.3A).   
Interestingly, injection of the MO2 morpholino, which targets the splice site of 
exon 1 to intron 1, did not have the same result.  Injection of MO2 at the 1x 
concentration consistently resulted in no remodeling defect of the cardinal vein and 
furthermore, consistently resulted in the upregulation of c-myb expression within the 
CHT (Figure 3.3B).  To determine the effect of MO2 on XP_697859.3 transcript 
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levels, mRNA was extracted at 24hpf, and QPCR was performed of the 
XP_697859.3 transcript.  We found that MO2 resulted in a slight upregulation of the 
XP_697859.3 transcript (Figure 3.3E).  Thus, it is likely that MO2 causes either 
increased stability of the mRNA, or otherwise results in the altered splicing of the 
transcript such that it is expressed at higher levels.  To confirm that increased 
expression of XP_697859.3 could result in the observed phenotype, mRNA was 
injected at .1ng and at .2ng per embryo, similar to the concentrations used to 
ectopically expressing other genes, and the embryos were screened at 36hpf.  
When mRNA was injected to overexpress XP_697859.3, there was no defect of 
vascular remodeling in the CHT and increased c-myb expression was observed 
(Figure 3.3B).  Thus, injection of MO2 is consistent with an overexpression 
phenotype of XP_697859.3.  Concurrent with this possibility is that co-injection of the 
wild-type XP_697859.3 transcript does not restore the normal phenotype. 
To further investigate these somewhat contradictory phenotypes, MO1 was 
coinjected with MO2.  We found that coinjection of the two morpholinos resulted in 
the rescue of the vein dilation and restoration of the c-myb expression within the 
CHT (Figure 3.3C).  Thus, it is likely that both morpholinos are targeting the same 
gene, but with different effects on protein levels.  Interesting, co-injection of MO1 
with a morpholinos targeting p53 also rescued the MO1, loss of flow phenotype 
(Figure 3.3C).  This is possibly due to a known role of PECAM1 in apoptotic 
signaling.  In mammalian systems, PECAM1 has been shown to protect from 
apoptosis by acting through p53.  It is possible that loss of XP_697859.3 activates a 
p53-dependent pathway and that cell death is partially responsible for the observed 
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phenotype.  Finally, to test how these two morpholinos were interacting, QPCR was 
performed of vascular and hematopoietic genes on mRNA from embryos injected 
with one or both of the morpholinos (Figure 3.3D).  Injection of MO1 resulted in 
upregulation of both hematopoietic and vascular markers, while injection of MO2 
only resulted in increased cmyb transcript.  Again, co-injection of either the p53 
morpholino or MO2 with MO1 suppressed the MO1 phenotype, suggesting that the 
two morpholinos cause opposing phenotypes and that MO1 acts through p53. 
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DISCUSSION 
Though Pecam1 is often used as a stereotypic marker for endothelial cells, its 
expression profile includes multiple hematopoietic cell types including platelets, 
lymphocytes, and hematopoietic stem cells[12, 13].  Its role in many of these tissues 
remains unclear, and though the knock-out mouse is viable, Pecam1 has been 
shown to have important roles in angiogenesis, and the response of endothelial cells 
to blood flow[1, 20].  As both endothelial and hematopoietic stem cells respond to 
blood flow and both express Pecam1, we sought to determine if Pecam1 could be a 
mediator in the hematopoietic response to blood flow.  To do this, we first identified a 
potential homolog of Pecam1 in zebrafish and then characterized its role in 
hematopoietic development.  We found that danio rerio XP_697859.3 displayed 
homology to PECAM1, was located on a chromosome syntenic to the human 
chromosome containing PECAM1, and the furthermore, modulation of XP_697859.3 
affected known flow sensitive pathways.  Interestingly, modulation of XP_697859.3 
was sufficient to also alter hematopoietic development, suggesting that indeed, 
PECAM1 could be involved in the response of HSCs to blood flow.  Though the 
mechanism by which this occurs remains uninvestigated, it is interesting to 
speculate that it is similar to the pathway in endothelial cells.   
In endothelial cells, Pecam1 becomes associated with the mechanosensory 
complex in response to hemodynamic force[1].  Interestingly, the mechanosensory 
complex within endothelial cells consists of PECAM1, VE-Cadherin, and VegfR2.  
Given that both PECAM1 and VE-Cadherin are expressed in hematopoietic stem 
cells which also respond to changes in blood flow, there is the possibility of a second 
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mechanosensory complex which exists in hematopoietic stem and progenitor cells.  
In this scenario, it would be interesting to consider that either the mechanosensory 
complex in HSCs responds differently than in endothelial cells, either due to the 
absence of VegfR2 or because of the inclusion of a different receptor tyronsine 
kinase. 
Recently, an additional gene has been identified in zebrafish that has 
homology to PECAM1.  This newly isolated gene, still identified as si:dkey-2370.8 
has 27% identity and 44% similarity to murine PECAM1.  Additionally, at least one of 
the ITIM phoshorylation sites appears to be conserved in this homolog.  It is possible 
that closer inspection of these genes will yield interesting divergent roles for 
PECAM1-like molecules in zebrafish.  Clearly, it is necessary to further investigate 
these genes, as well as the possible overlap and divergence of their functions before 
making any claims as to their effects on hematopoiesis in zebrafish. 
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FIGURES 
Figure 3.1:  Identification XP-697859.3 as a potential homolog to PECAM1. 
 
 HsPECAM1 was aligned against danio rerio XP_697859.3 using multalign (A).  The 
synteny of the chromosomes containing human PECAM1 and danio rerio 
XP_697859.3 (chromosomes 17 and 3 respectively) were examined using cinteny 
(B).  The phylogenic analysis of the putative PECAM homologs is shown (C).     
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Figure 3.2:  Characterization of XP_697859.3.  
 
The full-length transcript of XP_697859.3 was used to probe for expression at 24hpf 
(A) and 48hpf (B).  Higher magnifcations of the 48hpf expression profiles are shown 
of the AGM (C) and the CHT (D).  RT-PCR was performed at multiple time-points to 
determine when XP_697859.3 was expressed (E).  RT-PCR was performed from 
wild-type and cloche mutants (F).  QPCR was performed on sorted endothelial 
populations (G). 
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Figure 3.3:  Characterization of XP_ 697859.3 morpholinos.   
 
Morpholinos were injected against control, tnnt2, or XP_697859.3.  The phenotype 
of MO1 or MO1 + wild-type transcript was compared with either control or tnnt2-MO 
injections (A).  The phenotype of MO2 was compared with mRNA injections (B).  
MO1 was co-injected with either MO2 or p53-MO (C).  QPCR was performed on 
morpholino-injected embryos (D, E).  
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CHAPTER 4 
Conclusions and Perspectives 
 The first observation of potential hematopoietic cells descending from the 
endothelium, made by Florence Sabin in the 1920s, was a powerful discovery for 
multiple reasons[1].  It suggested that endothelial cells were not completely a 
terminally differentiated cell, an idea that may have seemed contrary to conventional 
thinking but has since found more acceptance.  The idea that a differentiated 
endothelial cell could become undifferentiated and become something different, 
especially a hematopoietic stem cell (HSC) capable of self-renewal and 
differentiation into multiple other lineages, must have seemed an interesting concept 
at first glance.  What was this cell doing?  Why would an endothelial cell do that?   
As studies have progressed, scientists have been able to add substantial 
knowledge to the regulation of this process.  We now have multiple markers of 
hemogenic endothelium, we know that it is conserved across species, and we know 
that it occurs in more than one vascular bed[2-4].  However, there are still many 
questions unanswered.  It is still not clear why some endothelial cells are hemogenic 
and others are not.  The pathways that promote hemogenic behavior are being 
elucidated, but slowly, mostly due to complications in distinguishing changes in 
overall hematopoiesis from changes in specific descendents of hemogenic 
endothelium[5].  The biological significance of this phenomenon remains almost 
completely untested, due to the near impossibility of eliminating HSCs descending 
from endothelial cells while leaving other HSCs intact.  One interesting question is 
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whether all endothelial cells possess the ability to become hemogenic, and to what 
extent these endothelial cells are hemogenic.   
My work has helped to clarify that non-aortic endothelial cells also possess 
the ability to produce HSCs.  We have provided evidence that venous endothelium 
can provide HSCs.  Though previously described hemogenic endothelium has been 
arterial in nature, studies have suggested that arterial differentiation was not a 
necessary component of hemogenic activity[3, 6-11].  The ability of venous 
endothelial cells to be hemogenic confirms that the arterial nature is not an absolute 
requirement of hemogenic endothelium.  This is interesting, because it presents the 
possibility that hematopoietic activity may be a more general property of endothelial 
cells than previously appreciated.  Also, it suggests that the pathways promoting 
hemogenic activity occur alongside of, but independent from, those promoting 
endothelial differentiation.  This second idea is supported by reports on stem cell 
leukemia (scl) activity in endothelial and hematopoietic tissues.  Loss of scl was 
shown to cause lack of hematopoietic specification, while not affecting angioblast 
development until a later angiogenic stage[11, 12]. 
As hematopoietic activity does occur specifically in endothelial cell—as 
opposed to randomly occurring in any stromal cell available, the implication is that 
there is a common denominator between the endothelial and hematopoietic 
pathways or that endothelial cells are more capable of becoming hemogenic than 
another cell type.  The questions that arise are what are the common denominators 
and at what point do hemogenic endothelial cells diverge from the endothelial 
program?  Current reports suggest, though they do not conclusively demonstrate, 
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that while it uses some of the same mediators, it is mechanistically independent of 
the arterial/venous specification, though occurring concordantly temporally.  
The role of blood flow in regulation of this pathway is also still unclear[5, 13].  
We identify blood flow as a regulator of hematopoietic maintenance.  This suggests 
that previous reports, detailing the effects of blood flow on hematopoietic 
development may be over-simplified, confounded with changes of hematopoietic 
maintenance.  While our results support that at least some hemogenic endothelium 
may be specified in the absence of blood flow, there is no expansion of this 
population, it may not bud from the vessel wall, and instead the HSCs are rapidly 
depleted.  Furthermore, our data support the hypothesis that Platelet Endothelial 
Cell Adhesion Molecule-1 (PECAM1), a mediator of the flow response in endothelial 
cells, is also involved in the response within hematopoietic cells.  There are several 
reasons this could be the case.  It could be an instance of HSCs sensing and 
responding directly to the presence of blood flow.  As HSCs retain a close 
association with the endothelium, it is formally possible that they remain in some 
contact with the vessel lumen and can sense and respond directly to blood flow.  
Alternatively, the flow signal could be relayed through the endothelial cells, and in 
the absence of that signal from the endothelial cells, the HSCs become depleted.  
Given the uniform depletion of cmyb+ cells we observed, and that not all cmyb+ cells 
were in direct contact with the vessel, this is more likely to be the case.  In either 
case, the role of blood flow in regulation of HSC maintenance is instructive as to the 
cues directing HSC recruitment to the downstream lineages.  Resolving this 
quandary will require sophisticated cell-autonomy experiments and/or conditional 
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knock-outs.  Though it is possible, and likely, that PECAM1 is involved in the 
transendothelial migration of hematopoietic cells, the role this plays in our observed 
phenotype is unclear.  
 
Future directions 
 Our experiments demonstrate the existence of hemogenic endothelium 
outside of the aorta-gonad-mesonephros (AGM), suggesting that more endothelial 
cells may possess hemogenic ability than previously appreciated.  However, these 
studies were subject to several limitations.  First, due to the limited availability of 
hemogenic markers, we relied substantially on the Tg(cmyb:GFP) line.  Exhaustive 
studies would require the generation of multiple hemogenic markers.  Currently, 
candidates such as runt-related transcription factor 1 (runx1), provide the most 
promising alternatives, and we are actively working to generate transgenic lines 
utilizing the hematopoietic specific enhancers of the runx1 gene.  However, evidence 
has suggested that event his approach will have limitations, as the requirement of 
runx1 in hematopoiesis is unclear.  Multiple studies have suggested that loss of 
runx1 does not have irreparable deleterious effects on hematopoietic 
development[14, 15].  It is likely that there are better markers that have yet to be 
characterized.  Identification of these markers would be aided by array experiments 
on isolated hemogenic endothelium.   
 Further work, that would be instrumental in moving the field forward, would 
address the biological consequences of loss of hemogenic endothelium.  As reports 
have shown that HSCs can have endothelial or non-endothelial origins, it is possible 
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that loss of either of these populations would have no effect on overall organism 
health, or alternatively, both populations could be absolutely required.  To address 
this issue, a combination of lineage tracing with cell-ablation technology could be 
employed[16, 17].  This would allow for the specific ablation of endothelium-derived 
HSCs, and then the questions of biological significance could be addressed. 
 Once the characterization of pathways directly involved in production of 
hemogenic endothelium have been clearly elucidated and distinguished from other 
populations of HSCs, the benefits to human health could be significant.  In cases 
where hematopoiesis has failed, or has become dysfunctional at the expense of the 
individuals health, endothelial cells could be the reservoir from which normal 
hematopoiesis could be restored.   
In our experiments where blood flow was modulated using chemical 
treatments, we showed that transendothelial migration of HSCs across the 
endothelium was not required to occur before cmyb+ cells could become depleted.  
As the XP-697859.3 morpholino injected embryos displayed a similar hematopoietic 
defect, it is suggested that PECAM1’s involvement in this process may be more as a 
flow sensor/responder or signaling molecule, and less as a mediator of 
transendothelial migration.  There are several experiments necessary to validate 
these findings.  We would need to first determine if the zebrafish homolog of 
PECAM1 acts in a similar manner as mammalian PECAM1 has been shown to act.  
We would need to test whether it was involved in integrin activation, changes in b-
catenin association, and phosphorylation of Vascular Endothelial Growth Factor 
Receptor-2 (VEGFR2, or kdrl in zebrafish).  Furthermore, the demonstration that XP-
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697859.3 is a functional homolog of PECAM1 has remained elusive.  A clear 
demonstration that mammalian PECAM1 can rescue the changes we see in the XP-
697859.3 morpholino injected embryos would clarify the functional relationship 
between these two genes. 
Taken together, the data all suggest that these two systems, hematopoietic 
and vascular, are intrinsically linked: they develop concordantly, they are co-
regulated, and they cross-talk.  The idea of transdifferentiation of specified cell types 
is still unusual in many systems, though now we know, that in the correct conditions, 
many cell types can be undifferentiated and driven towards alternative cell fates[18, 
19].  What makes hemogenic endothelium still unique, is that it occurs normally in 
the organism, be it zebrafish or mice.     
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